| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,101 | 24,754 | 22,459 | 23,499 | | Cost of Revenue | 16,164 | 15,839 | 15,406 | 13,915 | | | Gross Profit | 9,937 | 8,915 | 7,053 | 9,584 | | | Operating Expenses | | Research Development | 4,274 | 4,098 | 3,694 | 4,051 | | Selling General and Administrative | 7,288 | 5,628 | 5,046 | 6,699 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 781 | 87 | 94 | 94 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,711) | (898) | (1,781) | (1,260) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,761) | (3,807) | (607) | 2,503 | | Earnings Before Interest And Taxes | (5,369) | (4,705) | (2,388) | 1,243 | | Interest Expense | (765) | 311 | 454 | 548 | | Income Before Tax | (4,604) | (5,016) | (2,842) | 695 | | Income Tax Expense | 33 | 319 | 123 | (738) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,637) | (5,335) | (2,965) | 1,433 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,637) | (5,335) | (2,965) | 1,433 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,637) | ($5,335) | ($2,965) | $1,433 |
|
0.51% Nasdaq 
Income Statement
